The FDA has expanded the indication for tiotropium (Spiriva Respimat) to include children age 6 and older, based on efficacy data similar to that in adults.
FDA approves Spiriva (tiotropium) for kids age 6+ with asthma
FDA approves Spiriva (tiotropium) for kids…
FDA approves Spiriva (tiotropium) for kids age 6+ with asthma
The FDA has expanded the indication for tiotropium (Spiriva Respimat) to include children age 6 and older, based on efficacy data similar to that in adults.